Company Filing History:
Years Active: 2004-2008
Title: Barbara Janssens: Innovator in Biotechnology
Introduction
Barbara Janssens is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of biotechnology, particularly in the areas of cardiomyopathies and neurological disorders. With a total of 2 patents, her work has the potential to impact both medical research and therapeutic applications.
Latest Patents
One of her latest patents is titled "α-catenin expressed in heart and testis." This invention relates to a novel α-catenin with a specific expression pattern primarily in the heart and testis. It further explores the use of this α-catenin in predicting, diagnosing, and treating cadherin-catenin related diseases, especially cardiomyopathies and male infertility. Another significant patent is "CDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation." This invention focuses on drug discovery, diagnosis, prognosis, and treatment of cancer and neurological disorders. It provides insights into protein-protein and protein-DNA interactions in pathways controlling cell growth and development, offering means to identify candidate drugs for therapy.
Career Highlights
Barbara Janssens is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie, where she conducts her research and develops her inventions. Her work has garnered attention for its innovative approach to addressing complex biological issues.
Collaborations
Throughout her career, Barbara has collaborated with notable colleagues, including Frans Van Roy and Ann Van Landschoot. These partnerships have enhanced her research and contributed to the advancement of biotechnology.
Conclusion
Barbara Janssens stands out as a key figure in biotechnology, with her patents paving the way for advancements in medical research and treatment options. Her innovative work continues to inspire and influence the field.